Screening in Trauma for Opioid Misuse Prevention
STOMP
STOMP
Sponsor study identifier
Secondary identifiers
OTHER · Study Team
OTHER · UW Madison
OTHER · UW Madison
OTHER · UW Madison
observational
346
1 country
1
Study Start
July 15, 2016
Actual (reported)Primary Completion
May 23, 2019
Actual (reported)Study Completion
June 1, 2020
Actual (reported)The current study seeks to begin the crucial work of creating effective protocols to prevent opioid misuse, addiction, and related complications by developing and pilot testing an opioid risk screening protocol at Wisconsin trauma centers.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 1, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 9, 2016
Actual (reported)July 15, 2016
Actual (reported)August 10, 2016
Actual (reported)May 23, 2019
Actual (reported)June 1, 2020
Actual (reported)Opioid use disorder (CIDI-SAM) or opioid misuse (COMM) Opioid Use Disorder in 6 Months Post Traumatic Injury
This data will be analyzed in tandem with patient demographics, physical and mental health, and hypothesized risk factors for opioid misuse.
6 months subject participation
Development of a screening tool for the risk of opioid misuse in patients with traumatic injury.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients of UW Trauma Inpatient Service with expected need for post discharge with outpatient opioid analgesia.
University of Wisconsin - Madison
Madison, Wisconsin, 53715, United States
Brown R, Deyo B, Riley C, Quanbeck A, Glass JE, Turpin R, Hetzel S, Nicholas C, Cruz M, Agarwal S. Screening in Trauma for Opioid Misuse Prevention (STOMP): study protocol for the development of an opioid risk screening tool for victims of injury. Addict Sci Clin Pract. 2017 Dec 4;12(1):28. doi: 10.1186/s13722-017-0097-6.
Randall Brown, MD, PhD
University of Wisconsin, Madison
346 participants (actual enrollment reported by the registry).
First Submitted
February 9, 2016
First Posted
August 10, 2016
Study Start
July 15, 2016
Actual (reported)Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL
Contact the study team to confirm eligibility.
Primary Completion
May 23, 2019
Actual (reported)Study Completion
June 1, 2020
Actual (reported)Last Updated
June 17, 2020
Record last verified: 2020-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: